Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Metabolic syndrome is linked to skin diseases, requiring integrated treatment and monitoring.

Early treatment with corticosteroids and immunosuppressants is crucial for managing Vogt-Koyanagi-Harada disease.

Improving gut health can enhance skin health and aid in treating skin diseases.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

Cell-mediated drug delivery systems improve skin disease treatment by using living cells for precise, prolonged, and less toxic therapy.

Higher levels of certain proteins in the blood are linked to more severe patchy alopecia areata.

Restoring hair bulb immune privilege is crucial for managing alopecia areata.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

Two plywood factory workers developed contact dermatitis from phenol-formaldehyde resin, a known allergen.

Eyelash alopecia areata often goes undiagnosed and can lead to complete eyelash regrowth, especially in younger patients.

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.

VKHD can include rare oral symptoms like discolored teeth.

Bioprinting is improving skin models for better testing of skin diseases without using animals.

Immune cells are crucial for normal skin development and their dysfunction can cause skin disorders.

Hair disorders need a holistic approach, including medical, cosmetic, and psychological support.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

People with alopecia areata often have higher rates of allergies and autoimmune diseases.

The monkey's hair loss was due to an autoimmune disease, not genetics.

Alfredo Rebora suggests a simpler classification for hair loss and a new test for easier diagnosis.

Human hair shows promise for non-invasive medical testing, but more research is needed to standardize its use.

Early baldness in men may indicate risks for obesity, metabolic syndrome, insulin resistance, and heart disease, similar to women with PCOS. Alopecia areata is often linked with autoimmune diseases and mental health issues. Certain hair disorders are due to genetic issues, and chemotherapy can cause hair loss through specific biological pathways. Iron deficiency's link to hair loss is still disputed.

Certain skin and family history markers predict vitiligo severity and treatment needs.

CD4 T cells need IFN-γ to cause hair loss in alopecia areata.

Insulin resistance significantly contributes to the development and severity of certain chronic skin diseases.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.